Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, is administered as a single injection once per week, not daily. This weekly dosing schedule maintains steady hormone levels in your bloodstream for seven days, allowing your body to build consistent appetite suppression and improved metabolic control.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Why Semaglutide Uses Weekly Dosing Instead of Daily Injections
Semaglutide has a long half-life of approximately seven days, meaning the medication stays active in your body for a full week. This extended duration allows a single injection to deliver therapeutic benefits throughout the entire week without requiring daily administration. Pharmaceutical design prioritizes patient convenience and consistent drug exposure.
Daily dosing would create unpredictable peaks and valleys in medication levels, potentially triggering more nausea and side effects. Weekly administration smooths out these fluctuations, giving your body time to adapt gradually to the GLP-1 receptor activation. Clinical studies show that steady-state semaglutide concentrations produce more reliable weight loss outcomes than variable dosing patterns.
How the Weekly Semaglutide Injection Schedule Works
You inject semaglutide once every seven days at the same time each week. Most patients choose the same day and time for consistency, such as Sunday morning. The medication enters subcutaneous tissue and releases gradually into the bloodstream over the following days.
Your dose may increase over time as your body adjusts, but your monthly cost remains fixed—PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) regardless of dose escalation. This predictable pricing model removes surprise costs as your clinician optimizes your therapy based on your weight loss response and tolerability.
Building Tolerance: Dose Escalation on the Weekly Schedule
Most semaglutide protocols begin at 0.25 mg weekly for four weeks to allow your body to acclimate. After that foundation period, doses typically increase by 0.25 mg increments every four weeks until reaching a maintenance dose of 1.0–2.4 mg weekly. This gradual escalation reduces nausea and gives your appetite-regulating centers time to recalibrate.
Even as your dose climbs throughout your treatment course, your monthly price with PlexusDx stays the same. This flat-rate model ensures financial predictability while your clinician focuses purely on clinical optimization rather than cost barriers. Your dose may need to go up. Your price won't.
Semaglutide Injection vs. Daily Oral Alternatives
PlexusDx offers both compounded semaglutide injection (weekly) and oral semaglutide (daily). The injection version maintains the proven once-weekly schedule backed by landmark trials, while the oral form allows patients who prefer tablets to receive semaglutide through daily dosing. Both forms activate the same GLP-1 receptor pathway, but bioavailability and dosing frequency differ significantly.
The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
When to Take Your Semaglutide Injection and Preparation Tips
Inject semaglutide the same day and time each week at home using an easy pen device. Most patients choose early morning or evening, whichever fits their routine. Consistency matters for maintaining steady blood levels, not the specific time of day.
Store your semaglutide pens in the refrigerator before use and keep them at room temperature for up to 30 days once started. Rotate injection sites between your abdomen, thigh, and upper arm to prevent lipohypertrophy (fat buildup). Always follow your clinician's injection instructions, and report any unusual reactions during your weekly check-ins.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.
Frequently Asked Questions
Can I take Ozempic every day instead of once weekly?
No. Semaglutide's formulation and pharmacology are designed specifically for once-weekly dosing. Taking it more frequently would disrupt the steady-state concentration your body needs and could trigger excessive side effects. Your clinician determines the optimal dose for you within the standard weekly schedule.
What happens if I miss a weekly semaglutide injection?
If you miss an injection by 1–2 days, take it as soon as you remember, then resume your regular weekly schedule. If more than two days have passed, skip that dose and inject on your regular day. Never double-dose to make up a missed injection. Contact your PlexusDx clinician if you consistently miss doses.
Will my semaglutide cost increase as my dose goes up?
No. PlexusDx compounded semaglutide injection maintains flat monthly pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of dose level. Your dose may need to go up. Your price won't. This pricing structure ensures your clinician can optimize your therapy without financial barriers.
Is weekly semaglutide injection safe for long-term use?
Yes. Semaglutide injections have been used safely for over a decade in clinical practice. Weekly dosing is supported by extensive research showing sustained weight loss and metabolic improvement over years of continuous therapy. Always maintain regular clinician check-ins to monitor your individual response and side effects.
Can my genetic profile affect how well weekly semaglutide works for me?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Lose Weight Like Ozempic: A Comprehensive Guide to Effective Weight Loss Solutions
Is Body Aches a Side Effect of Zepbound?